Sweet Basil (Ocimum basilicum L.)―A Review of Its Botany, Phytochemistry, Pharmacological Activities, and Biotechnological Development
Nabilah Sekar Azizah, Budi Irawan, Joko Kusmoro, Wahyu Safriansyah, Kindi Farabi, Dina Oktavia, Febri Doni, Mia Miranti · 2023
Read Sweet Basil (Ocimum basilicum L.)―A Review of Its Botany, Phytochemistry, Pharmacological Activities, and Biotechnological Development by Nabilah Sekar Azizah, Budi Irawan, Joko Kusmoro, Wahyu Safriansyah, Kindi Farabi, Dina Oktavia, Febri Doni, Mia Miranti (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10748370.txt.
Description
Nabilah Azizah and co-authors review sweet basil as a source of natural medicines in a 2023 paper. Drug resistance and side effects push demand for plant based options. Basil's chemistry, led by compounds such as linalool and eugenol, shows activity against viruses, bacteria, and fungi in lab studies, plus antioxidant, blood sugar, nerve, and cancer related effects.
Healers have used the herb for centuries against flu, fever, colds, and gut, breathing, and fertility complaints. The review also covers basil based nanotechnology, which the authors see as a route to stronger products. They frame the plant as a rich but still early stage drug resource.
Catalog record
| CREATOR | Nabilah Sekar Azizah, Budi Irawan, Joko Kusmoro, Wahyu Safriansyah, Kindi Farabi, Dina Oktavia, Febri Doni, Mia Miranti |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |